[1]
K. Hafidh, “Efficacy and safety of Dapagliflozin vs. Canagliflozin in addition to metformin for treatment of type 2 diabetes, a randomized, double-blind, non-inferiority clinical trial”, PPCR, vol. 2, no. 1, Mar. 2016.